Glaxo's Alli Favored For OTC Weight-Loss Use By FDA Joint Panel

FDA's Nonprescription Drugs and Endocrinologic & Metabolic Drugs advisory committees voted 11-3 in favor of making Xenical available over the counter.

More from Archive

More from Pink Sheet